Credit: PROFESSOR JOHN ZAJICEK/Science Source
And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.
The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.
Walk with us.
From popular Instagram posts to the cover of People magazine, actress Selma Blair has become the face of multiple sclerosis in America this year. Her public profile emphasizes her glamour, her grit, and something else – a drastic, expensive and potentially dangerous stem-cell treatment that “reboots” the immune system. Now, neurologists are getting questions about the procedure she’s undergoing, and patients are learning that it can have dramatic impact but isn’t appropriate for many patients.
Region- and lineage-specific transcriptomic changes appear to be responsible for the characteristic pathobiology of multiple sclerosis (MS).
A study that used single-nucleus RNA sequencing to assess changes in cell lineages in MS lesions has shed light on the selective cortical neuron damage and glial activation that contribute to the progression of MS lesions.
Multiple sclerosis patients who are young, male and have mild disability are more likely to be employed, based on a recent analysis of multiple sclerosis registries across North America, Germany, and the United Kingdom.